Eli Lilly and Boehringer Ingelheim urge women to become their own heart health advocates in new campaign

Nicole DeFeudis

Editor

The heart failure market got a little more crowded last summer when Eli Lilly and Boehringer Ingelheim expanded the label on their blockbuster diabetes drug Jardiance. Now, the companies are teaming up to tell women — who often go misdiagnosed — to listen to their hearts.

Lilly and BI’s new “Hear Your Heart” campaign encourages women to prioritize heart health, especially Black and Latina women who are at a greater risk. The campaign website features facts about heart failure and videos from a heart failure patient and cardiologist.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

BECOME A PREMIUM SUBSCRIBER

Eli Lilly and Boehringer Ingelheim urge women to become their own heart health advocates in new campaign

Nicole DeFeudis

Editor

Unlock this article instantly by becoming a free subscriber.

Cash, chips and talent: Inside Nvidia's plan to dominate biotech's AI revolution

A majority of pharma and biotech companies prohibit ChatGPT use, survey finds

Senate bill targeting WuXi won't affect federal spending, CBO says

GSK unveils long-term Shingrix data as shingles competition heats up

Vertex, Alpine’s IgAN drug has Humira-like potential. But not all indications are created equal

Rare neuro disorder offers new area for competition, analysts say: #AAN24

Eli Lil­ly and Boehringer In­gel­heim urge women to be­come their own heart health ad­vo­cates in new cam­paign

Nicole DeFeudis

Editor

Unlock this article instantly by becoming a free subscriber.

more like this

Cash, chips and tal­ent: In­side Nvidi­a's plan to dom­i­nate biotech's AI rev­o­lu­tion

A ma­jor­i­ty of phar­ma and biotech com­pa­nies pro­hib­it Chat­G­PT use, sur­vey finds

Sen­ate bill tar­get­ing WuXi won't af­fect fed­er­al spend­ing, CBO says

GSK un­veils long-term Shin­grix da­ta as shin­gles com­pe­ti­tion heats up

Ver­tex, Alpine’s IgAN drug has Hu­mi­ra-like po­ten­tial. But not all in­di­ca­tions are cre­at­ed equal

Rare neu­ro dis­or­der of­fers new area for com­pe­ti­tion, an­a­lysts say: #AAN24

Eli Lilly and Boehringer Ingelheim urge women to become their own heart health advocates in new campaign

Cash, chips and talent: Inside Nvidia's plan to dominate biotech's AI revolution

A majority of pharma and biotech companies prohibit ChatGPT use, survey finds

Senate bill targeting WuXi won't affect federal spending, CBO says

GSK unveils long-term Shingrix data as shingles competition heats up

Vertex, Alpine’s IgAN drug has Humira-like potential. But not all indications are created equal

Rare neuro disorder offers new area for competition, analysts say: #AAN24